A new development is underway as Cipla USA Inc., a subsidiary of Cipla Limited (BSE: 500087) (NSE: CIPLA), is preparing for an imminent launch in Mumbai, India and Warren, N.J. The announcement was made on April 3, 2026, without citing the source. The company has received official approval from the U.S. Food and Drug Administration (FDA).
